Mr Huw Mottram
Core Technologies Hub Manager
School of Biosciences
Publication
2017
- Pope, S. J. A., Langdon-Jones, E., Jones, A., Williams, C. F., Hayes, A. J., Lloyd, D. and Mottram, H. J. 2017. Anticancer, azonafide-inspired fluorescent ligands and their rhenium(I) complexes for cellular imaging. European Journal of Inorganic Chemistry 2017(3), pp. 759-766. (10.1002/ejic.201601271)
2015
- Langdon-Jones, E. E. et al. 2015. Alkynyl-naphthalimide fluorophores: gold coordination chemistry and cellular imaging applications. Inorganic Chemistry 54(13), pp. 6606-6615., article number: 150618152106000. (10.1021/acs.inorgchem.5b00954)
- Gee, J. M. et al. 2015. A new cell panel to study oestrogen receptor loss in acquired endocrine resistant breast cancer. Cancer Research 75(9), article number: P3-05-19.
2014
- Gee, J. M. W. et al. 2014. Increased Ret signalling and impact of vandetanib in acquired tamoxifen resistant breast cancer. Cancer Research 74(19), article number: 738. (10.1158/1538-7445.AM2014-738)
- Jordan, N. J. et al. 2014. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Research 16(1), pp. -., article number: R12. (10.1186/bcr3604)
2012
- Balasingham, R., Williams, C. F., Mottram, H. J., Coogan, M. P. and Pope, S. J. A. 2012. Gold(I) complexes derived from alkynyloxy-substituted anthraquinones: Syntheses, luminescence, preliminary cytotoxicity, and cell imaging studies. Organometallics 31(16), pp. 5835-5843. (10.1021/om300475y)
- Mullice, L. A., Mottram, H. J., Hallett, A. J. and Pope, S. J. A. 2012. Gold(I) complexes incorporating emissive mercapto-pteridine ligands: Syntheses, X-ray structure, luminescence and preliminary cytotoxic evaluation. European Journal of Inorganic Chemistry 2012(18), pp. 3054-3060. (10.1002/ejic.201200147)
2010
- Mehellou, Y., Valente, R., Mottram, H. J., Walsby, E. J., Mills, K. I., Balzarini, J. and McGuigan, C. 2010. Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism. Bioorganic & Medicinal Chemistry 18(7), pp. 2439-2446. (10.1016/j.bmc.2010.02.059)
Articles
- Pope, S. J. A., Langdon-Jones, E., Jones, A., Williams, C. F., Hayes, A. J., Lloyd, D. and Mottram, H. J. 2017. Anticancer, azonafide-inspired fluorescent ligands and their rhenium(I) complexes for cellular imaging. European Journal of Inorganic Chemistry 2017(3), pp. 759-766. (10.1002/ejic.201601271)
- Langdon-Jones, E. E. et al. 2015. Alkynyl-naphthalimide fluorophores: gold coordination chemistry and cellular imaging applications. Inorganic Chemistry 54(13), pp. 6606-6615., article number: 150618152106000. (10.1021/acs.inorgchem.5b00954)
- Gee, J. M. et al. 2015. A new cell panel to study oestrogen receptor loss in acquired endocrine resistant breast cancer. Cancer Research 75(9), article number: P3-05-19.
- Gee, J. M. W. et al. 2014. Increased Ret signalling and impact of vandetanib in acquired tamoxifen resistant breast cancer. Cancer Research 74(19), article number: 738. (10.1158/1538-7445.AM2014-738)
- Jordan, N. J. et al. 2014. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Breast Cancer Research 16(1), pp. -., article number: R12. (10.1186/bcr3604)
- Balasingham, R., Williams, C. F., Mottram, H. J., Coogan, M. P. and Pope, S. J. A. 2012. Gold(I) complexes derived from alkynyloxy-substituted anthraquinones: Syntheses, luminescence, preliminary cytotoxicity, and cell imaging studies. Organometallics 31(16), pp. 5835-5843. (10.1021/om300475y)
- Mullice, L. A., Mottram, H. J., Hallett, A. J. and Pope, S. J. A. 2012. Gold(I) complexes incorporating emissive mercapto-pteridine ligands: Syntheses, X-ray structure, luminescence and preliminary cytotoxic evaluation. European Journal of Inorganic Chemistry 2012(18), pp. 3054-3060. (10.1002/ejic.201200147)
- Mehellou, Y., Valente, R., Mottram, H. J., Walsby, E. J., Mills, K. I., Balzarini, J. and McGuigan, C. 2010. Phosphoramidates of 2′-β-d-arabinouridine (AraU) as phosphate prodrugs; design, synthesis, in vitro activity and metabolism. Bioorganic & Medicinal Chemistry 18(7), pp. 2439-2446. (10.1016/j.bmc.2010.02.059)